Soulbrain Co., Ltd. – Trademark Portfolio

Entity Type: 99

Soulbrain Co., Ltd. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include LEO, SUL, WCNE, SBACT, and PURIEL. The owner is based in Seongnam, Gyeonggi-do.

(Sampyeong-dong, Soulbrain)

34, Pangyo-ro 255beon-gil, Bundang-gu

Seongnam, Gyeonggi-do 13486 , KR

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SBACT
SBACT
Registered 2023
SUL
SUL
Registered 2022
LEO
LEO
Registered 2020
PURIEL
PURIEL
Registered 2020
SB-SUP
SB-SUP
Registered 2020
WCNE
WCNE
Registered 2020

Trademark Classifications

Soulbrain Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Soulbrain Co., Ltd. have?

Soulbrain Co., Ltd. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending.

What trademark classes does Soulbrain Co., Ltd. file in?

Soulbrain Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Soulbrain Co., Ltd.'s most well-known trademarks?

Soulbrain Co., Ltd.'s registered trademark portfolio includes well-known marks such as LEO, SUL, WCNE, SBACT, and PURIEL. These are among 6 currently registered trademarks in the portfolio.

What is Soulbrain Co., Ltd.'s trademark registration success rate?

Soulbrain Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.